Project 55.2: Investigating local protein synthesis deficits in schizophrenia
Lead Research Organisation:
King's College London
Department Name: Clinical Neuroscience
Abstract
Genome wide association studies (GWAS) link variation in the ZNF804A gene to increased risk
for schizophrenia and bipolar disorder. However, the function(s) of the protein encoded by the
ZNF804A gene remains largely unknown and putative disease causing mechanisms cannot be
established. Whilst ZNF804A may function as a transcription factor, work from our group
revealed that the protein encoded by ZNF804A resided at synapses. Furthermore, it was
required for both the maintenance of synapse number and the ability of a cell to remodel its
synapses in response to synaptic stimulation (activity-dependent signalling). More recently, yet
another role for ZNF804A has been described, linking it to the control of cellular protein
synthesis. Work from our lab has now linked these lines of evidence to suggest that ZNF804A
is important for controlling activity-dependent protein synthesis.
These data suggest a testable hypothesis that ZNF804A plays a critical role in mediating
activity-dependent changes in the synaptic proteome. The aim of this project is therefore to
investigate the consequence of manipulating ZNF804A gene expression levels on how a
neuron responds to activity-dependent stimulation. This will be achieved using a range of
biochemical and cutting edge imaging techniques (including super-resolution imaging) to
determine how activity-dependent protein synthesis is impacted and what synaptic proteins are
affected. These studies will be the first to determine whether deficits in activity-dependent
synthesis of synaptic proteins is a mechanism contributing to synaptic dysfunction in
schizophrenia and provide a potential mechanistic explanation linking genetic variation in
ZNF804A and psychosis risk.
for schizophrenia and bipolar disorder. However, the function(s) of the protein encoded by the
ZNF804A gene remains largely unknown and putative disease causing mechanisms cannot be
established. Whilst ZNF804A may function as a transcription factor, work from our group
revealed that the protein encoded by ZNF804A resided at synapses. Furthermore, it was
required for both the maintenance of synapse number and the ability of a cell to remodel its
synapses in response to synaptic stimulation (activity-dependent signalling). More recently, yet
another role for ZNF804A has been described, linking it to the control of cellular protein
synthesis. Work from our lab has now linked these lines of evidence to suggest that ZNF804A
is important for controlling activity-dependent protein synthesis.
These data suggest a testable hypothesis that ZNF804A plays a critical role in mediating
activity-dependent changes in the synaptic proteome. The aim of this project is therefore to
investigate the consequence of manipulating ZNF804A gene expression levels on how a
neuron responds to activity-dependent stimulation. This will be achieved using a range of
biochemical and cutting edge imaging techniques (including super-resolution imaging) to
determine how activity-dependent protein synthesis is impacted and what synaptic proteins are
affected. These studies will be the first to determine whether deficits in activity-dependent
synthesis of synaptic proteins is a mechanism contributing to synaptic dysfunction in
schizophrenia and provide a potential mechanistic explanation linking genetic variation in
ZNF804A and psychosis risk.
Organisations
Publications
Couch ACM
(2023)
Acute IL-6 exposure triggers canonical IL6Ra signaling in hiPSC microglia, but not neural progenitor cells.
in Brain, behavior, and immunity
Pavlinek A
(2022)
Interferon-? exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression.
in Frontiers in psychiatry
Studentship Projects
Project Reference | Relationship | Related To | Start | End | Student Name |
---|---|---|---|---|---|
MR/N013700/1 | 30/09/2016 | 29/09/2025 | |||
2290929 | Studentship | MR/N013700/1 | 30/09/2019 | 29/06/2023 | Laura Sichlinger |